These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 11816545)
1. Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects. Di Paolo MC; Paoluzi OA; Pica R; Iacopini F; Crispino P; Rivera M; Spera G; Paoluzi P Dig Liver Dis; 2001 Oct; 33(7):563-9. PubMed ID: 11816545 [TBL] [Abstract][Full Text] [Related]
2. The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine. Donald IP; Wilkinson SP Postgrad Med J; 1985 Dec; 61(722):1047-8. PubMed ID: 2869480 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine. Rao SS; Cann PA; Holdsworth CD Scand J Gastroenterol; 1987 Apr; 22(3):332-6. PubMed ID: 2884724 [TBL] [Abstract][Full Text] [Related]
6. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Feagan BG; Macdonald JK Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889 [TBL] [Abstract][Full Text] [Related]
7. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Rachmilewitz D BMJ; 1989 Jan; 298(6666):82-6. PubMed ID: 2563951 [TBL] [Abstract][Full Text] [Related]
8. Reversal of male infertility on changing treatment from sulphasalazine to 5-aminosalicylic acid. Cann PA; Holdsworth CD Lancet; 1984 May; 1(8386):1119. PubMed ID: 6144844 [No Abstract] [Full Text] [Related]
9. Treatment of ulcerative colitis with olsalazine and sulphasalazine: efficacy and side-effects. Ewe K; Eckardt V; Kanzler G Scand J Gastroenterol Suppl; 1988; 148():70-5. PubMed ID: 2906479 [TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group. Rutgeerts P Aliment Pharmacol Ther; 1989 Apr; 3(2):183-91. PubMed ID: 2577483 [TBL] [Abstract][Full Text] [Related]
11. Sulphasalazine: a review of 40 years' experience. Watkinson G Drugs; 1986; 32 Suppl 1():1-11. PubMed ID: 2877847 [TBL] [Abstract][Full Text] [Related]
12. Is maintenance therapy always necessary for patients with ulcerative colitis in remission? Ardizzone S; Petrillo M; Imbesi V; Cerutti R; Bollani S; Bianchi Porro G Aliment Pharmacol Ther; 1999 Mar; 13(3):373-9. PubMed ID: 10102971 [TBL] [Abstract][Full Text] [Related]
13. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications. Schroeder KW Scand J Gastroenterol Suppl; 2002; (236):42-7. PubMed ID: 12408503 [TBL] [Abstract][Full Text] [Related]
14. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse. Riley SA; Mani V; Goodman MJ; Herd ME; Dutt S; Turnberg LA Gut; 1988 May; 29(5):669-74. PubMed ID: 2899536 [TBL] [Abstract][Full Text] [Related]
15. Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis. Birketvedt GS; Berg KJ; Fausa O; Florholmen J Inflamm Bowel Dis; 2000 Nov; 6(4):275-9. PubMed ID: 11149559 [TBL] [Abstract][Full Text] [Related]
16. 5-Aminosalicylic acid, a specific drug for ulcerative colitis. Hauso Ø; Martinsen TC; Waldum H Scand J Gastroenterol; 2015 Aug; 50(8):933-41. PubMed ID: 25733192 [TBL] [Abstract][Full Text] [Related]